Gene · 1830
Papers2,614
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,614
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dupilumab Combined with Glucocorticoids in the Treatment of Pemphigus Vegetans: Case Report. | Case Rep Dermatol | 2026 | 42290678 | PubTator, text mining | PubMed |
| ZCRB1 promotes proliferation and metastasis of lung squamous cell carcinoma by stabilizing DSG3 mRNA. | Cell Signal | 2026 | 42259463 | PubTator, text mining | PubMed |
| A diagnostically challenging case of pemphigus foliaceus without histologic evidence of acantholysis. | Dermatol Online J | 2026 | 42246332 | PubTator, text mining | PubMed |
| Successful treatment of paraneoplastic pemphigus associated with Castleman's disease using membrane therapeutic plasma exchange: A case report. | Transfus Apher Sci | 2026 | 42190363 | PubTator, text mining | PubMed |
| NK cell hyperactivation drives macrophage repolarization and limits M2 bias in pemphigus vulgaris. | Front Immunol | 2026 | 42183286 | PubTator, text mining | PubMed |
| Pemphigus Herpetiformis Presenting With Mucosal Involvement: A Rare Clinical Presentation. | Cureus | 2026 | 42093787 | PubTator, text mining | PubMed |
| Non-COVID-19 Vaccinations and the Induction of Autoantibodies in Pemphigus Diseases: A Review of the Speculative Issue and Our Clinical-Laboratory Experience. | Antibodies (Basel) | 2026 | 42041392 | PubTator, text mining | PubMed |
| Kallikrein related peptidases 7 and 10 and their substrate desmoglein 3 are upregulated in early stage pancreatic cancerous lesions. | Sci Rep | 2026 | 41974993 | PubTator, text mining | PubMed |
| Lupus erythematosus-specific bullous lesions: A case report. | Medicine (Baltimore) | 2026 | 41894261 | PubTator, text mining | PubMed |
| A Novel Model System to Identify Cellular and Molecular Defects Underlying Rare Genetic Disorders. | Exp Dermatol | 2026 | 41795154 | PubTator, text mining | PubMed |
| Diagnostic Accuracy of Anti-Desmoglein 1 and 3 Antibodies by Enzyme-Linked Immunosorbent Assay (ELISA) in Pemphigus Vulgaris. | J Coll Physicians Surg Pak | 2026 | 41792058 | PubTator, text mining | PubMed |
| Could vector-derived cadherin mimicry contribute to pemphigus vulgaris? An immunogenetic and in silico study involving HLA-DRB104:02 and 14:01. | Front Immunol | 2026 | 41789085 | PubTator, text mining | PubMed |
| Case Report: Pemphigus following COVID-19 mRNA vaccination: two cases achieving long-term remission without relapse. | Front Immunol | 2026 | 41743705 | PubTator, text mining | PubMed |
| A case of juvenile pemphigus vulgaris effectively treated with dupilumab. | JAAD Case Rep | 2026 | 41728065 | PubTator, text mining | PubMed |
| Identification of circulatory neuro-related proteins in Parkinson's disease: an integrated genetic-proteomic-clinical study. | EBioMedicine | 2026 | 41724112 | PubTator, text mining | PubMed |
| Caspase-activation powers anti-Desmoglein 3-induced acantholysis in human epidermis. | Cell Death Discov | 2026 | 41714593 | PubTator, text mining | PubMed |
| Pemphigus Vulgaris Mimicking Behçet's Syndrome With Oral and Vulvar Ulcers: A Case Report. | Cureus | 2026 | 41710829 | PubTator, text mining | PubMed |
| Paraneoplastic Pemphigus and Liver Biopsy Needle Track Dissemination in Hepatocellular Carcinoma: A Case Report. | GE Port J Gastroenterol | 2026 | 41704892 | PubTator, text mining | PubMed |
| Dihydroartemisinin attenuates pemphigus vulgaris by regulating Dsg3 and the TLR9/NF-κB pathway. | Am J Transl Res | 2026 | 41676306 | PubTator, text mining | PubMed |
| Correlation of platelet-related parameters and autoantibodies in patients with autoimmune bullous diseases. | Lab Med | 2026 | 41672569 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1830/papers?page=2